Peptides are everywhere, but do you actually know where they come from?
In this episode, we dig into the peptide supply chain and the difference between a product being sold, tested, filled, or packaged in the United States and the actual peptide API being manufactured here.
We break down why U.S. pharmaceutical companies rely heavily on foreign API manufacturing, the major countries behind peptide production, and why the country of origin doesn't necessarily determine quality.
We also take a closer look at BPC-157, what the research actually shows, what we still don't know about human safety and effectiveness, and why “research use only,” “99% purity,” and “Made in the USA” don't necessarily mean what consumers think they mean.
Finally, we tackle the bigger question: How much should FDA approval, or lack of approval, actually influence the way we evaluate risk? We compare the scrutiny surrounding experimental peptides with substances that have been legally permitted in the American food supply despite ongoing safety debates.
No hype. No fear mongering. Just a deeper look at the science, the supply chain, and the questions you should be asking before believing what's on the label.
DISCLAIMER: The views and opinions expressed on this podcast are for informational and entertainment purposes only and should not be considered medical advice. Always consult a licensed physician or qualified healthcare professional before making decisions regarding your health, medications, supplements, peptides, or treatment.